BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6854699)

  • 1. Regulation of Leishmania populations within the host. V. Resistance to L.donovani in wild mice.
    Blackwell JM
    J Trop Med Hyg; 1983 Feb; 86(1):17-22. PubMed ID: 6854699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.
    Bradley DJ
    Clin Exp Immunol; 1977 Oct; 30(1):130-40. PubMed ID: 606434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.
    Bradley DJ; Kirkley J
    Clin Exp Immunol; 1977 Oct; 30(1):119-29. PubMed ID: 606433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse.
    Bradley DJ; Taylor BA; Blackwell J; Evans EP; Freeman J
    Clin Exp Immunol; 1979 Jul; 37(1):7-14. PubMed ID: 290436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
    Rezai HR; Farrell J; Soulsby EL
    Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci.
    Leclercq V; Lebastard M; Belkaid Y; Louis J; Milon G
    J Immunol; 1996 Nov; 157(10):4537-45. PubMed ID: 8906832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic susceptibility to parasitic infections in Mus musculus].
    Fragoso G; Sciutto E; Estrada I; Larralde C
    Rev Latinoam Microbiol; 1991; 33(2-3):171-80. PubMed ID: 1670483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feline leishmaniasis: what's the epidemiological role of the cat?].
    Mancianti F
    Parassitologia; 2004 Jun; 46(1-2):203-6. PubMed ID: 15305717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative infectivity of a Kenyan strain of Leishmania donovani amastigotes for Rattus rattus and the laboratory white rat.
    Shatry AM; Anjili C; Hendricks LD
    Acta Trop; 1987 Dec; 44(4):409-14. PubMed ID: 2894131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran.
    Mohebali M; Javadian E; Yaghoobi-Ershadi MR; Akhavan AA; Hajjaran H; Abaei MR
    East Mediterr Health J; 2004; 10(4-5):591-9. PubMed ID: 16335651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
    Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
    J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral model of leishmaniasis in congenic strains of mice.
    Semprevivo LH; DeTolla LJ; Passmore HC; Palczuk NC
    J Parasitol; 1981 Feb; 67(1):8-14. PubMed ID: 7229823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum.
    Binhazim AA; Shin SS; Chapman WL; Olobo J
    Lab Anim Sci; 1993 Feb; 43(1):37-47. PubMed ID: 8459677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-based diagnosis for detection of Leishmania in skin and blood of rodents from an endemic area of cutaneous and visceral leishmaniasis in Brazil.
    Oliveira FS; Pirmez C; Pires MQ; Brazil RP; Pacheco RS
    Vet Parasitol; 2005 May; 129(3-4):219-27. PubMed ID: 15845276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
    Afrin F; Ali N
    J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.